Goldman Sachs’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-8
Closed -$7K 7051
2016
Q4
$7K Hold
8
﹤0.01% 6795
2016
Q3
$8K Buy
+8
New +$7.83K ﹤0.01% 6894
2015
Q4
Sell
-1,000
Closed -$643K 7372
2015
Q3
$643K Sell
1,000
-1,058
-51% -$804K ﹤0.01% 4898
2015
Q2
$1.86M Buy
2,058
+205
+11% +$229K ﹤0.01% 3895
2015
Q1
$1.57M Buy
1,853
+603
+48% +$833K ﹤0.01% 4017
2014
Q4
$2.17M Hold
1,250
﹤0.01% 3757
2014
Q3
$1.91M Sell
1,250
-1,604
-56% -$2.91M ﹤0.01% 3976
2014
Q2
$5.72M Buy
2,854
+1,375
+93% +$2.3M ﹤0.01% 2893
2014
Q1
$2.71M Buy
+1,479
New +$3.43M ﹤0.01% 3673

Other funds holding VIVS

Goldman Sachs's VIVS Position: Q1 2026 in Review

Goldman Sachs opened a new position in VivoSim Labs (VIVS) in Q1 2026: 16,072 shares worth $23K. The stake represents ﹤0.01% of the portfolio and ranks #6353 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in VIVS as recently as Q1 2021.

Goldman Sachs first reported a position in VIVS in Q3 2013 and has held it in 26 quarters since. The position peaked at $6.36M in Q2 2014. 24 funds tracked by Wall St. Rank hold VIVS as of Q1 2026.

  • Goldman Sachs held 16,072 shares of VivoSim Labs worth $23K as of Q1 2026.
  • VivoSim Labs was a new Goldman Sachs position in Q1 2026.
  • VivoSim Labs made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6353 holding.
  • Goldman Sachs first reported a position in VivoSim Labs in Q3 2013 and has held it in 26 quarters since.
  • Goldman Sachs's VivoSim Labs position peaked at $6.36M in Q2 2014.
  • 24 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.